Search | IOVS | ARVO Journals

Showing 1 – 20 of 24

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2024

Aqueous Humor Proteome Associated with Incomplete Anti-VEGF Response in Diabetic Macular Edema

Lasse Joergensen Cehofski; Jessica Cao; Kentaro Kojima; Noëlle Bakker; Ingeborg Klaassen; Bent Honoré; Henrik Vorum; Charles Clifton Wykoff

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):863.

ARVO Annual Meeting Abstract June 2024

Correlation of Aqueous and Vitreous Protein Levels in Proliferative Diabetic Retinopathy and Their Association with Clinical Parameters

Ingeborg Klaassen; Reinier O. Schlingemann; David H. W. Steel

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):855.

ARVO Annual Meeting Abstract June 2024

Shared pathophysiology in the neurovascular unit of the human retina and Alzheimer’s brain in type 2 diabetes

Noëlle Bakker; Cornelis J.F. van Noorden; Reinier O. Schlingemann; Ingeborg Klaassen

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):333.

ARVO Annual Meeting Abstract June 2024

Identifying PLVAP-associated proteins involved in breakdown of the blood-retinal barrier in DME

Mathilda van Breest Smallenburg; Reinier O. Schlingemann; Cornelis J.F. van Noorden; Ingeborg Klaassen

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):319.

ARVO Annual Meeting Abstract June 2024

iPSC-derived blood vessel organoids to study pathological angiogenesis in ocular neovascular diseases

Paola Serrano Martinez; Maxime Cammeraat; Lugmaan Ibrahim; Cornelis J.F. van Noorden; Reinier O. Schlingemann; Ingeborg Klaassen

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):4540.

ARVO Annual Meeting Abstract June 2023

Cortisol-modulated Barrier Properties of Cultured Choroidal Endothelial Cells: a Model to Study Central Serous Chorioretinopathy

Sekar Galuh; Elon van Dijk; Esmeralda K. Bosma; Joost Brinks; Reinier O. Schlingemann; Ingeborg Klaassen; Onno C. Meijer; Camiel J.F. Boon

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3008.

ARVO Annual Meeting Abstract June 2020

MicroRNA levels as a biomarker for anti-VEGF response in patients with diabetic macular edema

Maartje J.C. Vader; Reinier O. Schlingemann; Ingeborg Klaassen

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):4355.

Articles May 2020

microRNA Expression Profile in the Vitreous of Proliferative Diabetic Retinopathy Patients and Differences from Patients Treated with Anti-VEGF Therapy

PDF

Julian Friedrich; David H. W. Steel; Reinier O. Schlingemann; Michael J. Koss; Hans-Peter Hammes; Guido Krenning; Ingeborg Klaassen
TAGS: micrornas, vitreous body, anti-vascular endothelial growth factor therapy
Trans. Vis. Sci. Tech.. 2020; 9(6):16. https://doi.org/10.1167/tvst.9.6.16

Includes: Supplemental Content

Retinal Cell Biology July 2017

TNFα-Induced Disruption of the Blood–Retinal Barrier In Vitro Is Regulated by Intracellular 3′,5′-Cyclic Adenosine Monophosphate Levels

PDF

Anne-Eva van der Wijk; Ilse M. C. Vogels; Cornelis J. F. van Noorden; Ingeborg Klaassen; Reinier O. Schlingemann
TAGS: cyclic amp, permeability, adenosine monophosphate, blood-retinal barrier
Invest. Ophthalmol. Vis. Sci.. 2017; 58(9):3496-3505. https://doi.org/10.1167/iovs.16-21091

Includes: Supplemental Content

Retina November 2016

Association of Circulating Markers With Outcome Parameters in the Bevacizumab and Ranibizumab in Diabetic Macular Edema Trial

PDF

Ward Fickweiler; Ingeborg Klaassen; Ilse M. C. Vogels; Johanna M. M. Hooymans; Bruce H. R. Wolffenbuttel; Leonoor I. Los; Reinier O. Schlingemann; for the BRDME Research Group
TAGS: bevacizumab, biological markers, diabetic macular edema, ranibizumab, rhodopsin, rna, messenger, visual acuity, plasma, anti-vascular endothelial growth factor therapy, eye
Invest. Ophthalmol. Vis. Sci.. 2016; 57(14):6234-6241. https://doi.org/10.1167/iovs.16-20157

ARVO Annual Meeting Abstract June 2015

CD34 marks angiogenic tip cells in human microvascular endothelial cell cultures .

Marchien Geesje Dallinga; Bahar Arik-Yetin; Richelle Kayser; Ilse Vogels; Ingeborg Klaassen; Cornelis van Noorden; Reinier Schlingemann; Ocular angiogenesis group

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):2306.

ARVO Annual Meeting Abstract April 2014

PLVAP Modulates Angiogenesis By Tuning VEGF Signaling In Endothelial Cells

Joanna Wisniewska-Kruk; Ingeborg Klaassen; Ilse M Vogels; Cornelis J Van Noorden; Reinier O Schlingemann; Ocular Angiogenesis Group

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):2241.

Retinal Cell Biology October 2013

Complement Factor C3a Alters Proteasome Function in Human RPE Cells and in an Animal Model of Age-Related RPE Degeneration

PDF

J. Emanuel Ramos de Carvalho; Ingeborg Klaassen; Ilse M. C. Vogels; Sabine Schipper-Krom; Cornelis J. F. van Noorden; Eric Reits; Theo G. M. F. Gorgels; Arthur A. B. Bergen; Reinier O. Schlingemann
TAGS: complement system proteins, multicatalytic endopeptidase complex, retinal pigment cell, tissue degeneration
Invest. Ophthalmol. Vis. Sci.. 2013; 54(10):6489-6501. https://doi.org/10.1167/iovs.13-12374

Biochemistry and Molecular Biology April 2010

Differential TGF-β Signaling in Retinal Vascular Cells: A Role in Diabetic Retinopathy?

PDF

Rob J. Van Geest; Ingeborg Klaassen; Ilse M. C. Vogels; Cornelis J. F. Van Noorden; Reinier O. Schlingemann
TAGS: diabetic retinopathy, proteins, rna, messenger, signal transduction, phosphorylation, endothelial cells
Invest. Ophthalmol. Vis. Sci.. 2010; 51(4):1857-1865. https://doi.org/10.1167/iovs.09-4181

ARVO Annual Meeting Abstract April 2009

Differential TGF-Beta Signaling Pathways in Retinal Endothelial Cells and Pericytes

R. J. van Geest; I. Klaassen; I. M. C. Vogels; C. J. F. van Noorden; R. O. Schlingemann

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):4979.

ARVO Annual Meeting Abstract May 2008

The Angio-Fibrotic Switch in Proliferative Diabetic Retinopathy: A Balance Shift Between the Growth Factors VEGF and CTGF

R. J. van Geest; E. J. Kuiper; P. Roestenberg; M. D. de Smet; J. C. van Meurs; M. W. Tanck; N. Oliver; I. Klaassen; C. J. F. van Noorden; R. O. Schlingemann

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):4904.

ARVO Annual Meeting Abstract May 2008

Connective Tissue Growth Factor Is Necessary for Retinal Capillary Basal Lamina Thickening in Diabetic Mice

I. Klaassen; E. J. Kuiper; R. van Zijderveld; P. Roestenberg; K. M. Lyons; R. Goldschmeding; C. J. F. van Noorden; R. O. Schlingemann

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):1325.

Retina September 2007

Effect of VEGF-A on Expression of Profibrotic Growth Factor and Extracellular Matrix Genes in the Retina

PDF

Esther J. Kuiper; John M. Hughes; Rob J. Van Geest; Ilse M. C. Vogels; Roel Goldschmeding; Cornelis J. F. Van Noorden; Reinier O. Schlingemann; Ingeborg Klaassen
TAGS: genes, retina, rna, messenger, vascular endothelial growth factor a, growth factor, connective tissue growth factor, extracellular matrix, immunohistochemistry
Invest. Ophthalmol. Vis. Sci.. 2007; 48(9):4267-4276. https://doi.org/10.1167/iovs.06-0804

ARVO Annual Meeting Abstract May 2007

Differential Expression of VEGF Receptor-2 in Retina of Diabetes Mellitus Type 1 and Type 2 Patients

A. N. Witmer; Ocular Angiogenesis Group AMC; I. Klaassen; J. Aten; C. J. F. van Noorden; R. O. Schlingemann

Invest. Ophthalmol. Vis. Sci.. 2007; 48(13):1367.

ARVO Annual Meeting Abstract May 2005

Increased Transcription of Connective Tissue Growth Factor in Daibetic Rat Retina: Attenuation With Aminoguanidine

J.M. Hughes; I. Klaassen; E. Kuiper; C.G. Schalkwijk; R.O. Schlingemann

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):439.

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Aqueous Humor Proteome Associated with Incomplete Anti-VEGF Response in Diabetic Macular Edema

Correlation of Aqueous and Vitreous Protein Levels in Proliferative Diabetic Retinopathy and Their Association with Clinical Parameters

Shared pathophysiology in the neurovascular unit of the human retina and Alzheimer’s brain in type 2 diabetes

Identifying PLVAP-associated proteins involved in breakdown of the blood-retinal barrier in DME

iPSC-derived blood vessel organoids to study pathological angiogenesis in ocular neovascular diseases

Cortisol-modulated Barrier Properties of Cultured Choroidal Endothelial Cells: a Model to Study Central Serous Chorioretinopathy

MicroRNA levels as a biomarker for anti-VEGF response in patients with diabetic macular edema

microRNA Expression Profile in the Vitreous of Proliferative Diabetic Retinopathy Patients and Differences from Patients Treated with Anti-VEGF Therapy

TNFα-Induced Disruption of the Blood–Retinal Barrier In Vitro Is Regulated by Intracellular 3′,5′-Cyclic Adenosine Monophosphate Levels

Association of Circulating Markers With Outcome Parameters in the Bevacizumab and Ranibizumab in Diabetic Macular Edema Trial

CD34 marks angiogenic tip cells in human microvascular endothelial cell cultures .

PLVAP Modulates Angiogenesis By Tuning VEGF Signaling In Endothelial Cells

Complement Factor C3a Alters Proteasome Function in Human RPE Cells and in an Animal Model of Age-Related RPE Degeneration

Differential TGF-β Signaling in Retinal Vascular Cells: A Role in Diabetic Retinopathy?

Differential TGF-Beta Signaling Pathways in Retinal Endothelial Cells and Pericytes

The Angio-Fibrotic Switch in Proliferative Diabetic Retinopathy: A Balance Shift Between the Growth Factors VEGF and CTGF

Connective Tissue Growth Factor Is Necessary for Retinal Capillary Basal Lamina Thickening in Diabetic Mice

Effect of VEGF-A on Expression of Profibrotic Growth Factor and Extracellular Matrix Genes in the Retina

Differential Expression of VEGF Receptor-2 in Retina of Diabetes Mellitus Type 1 and Type 2 Patients

Increased Transcription of Connective Tissue Growth Factor in Daibetic Rat Retina: Attenuation With Aminoguanidine

To View More...

You must be signed into an individual account to use this feature.